529 related articles for article (PubMed ID: 31828982)
1. Identification of microRNAs in skeletal muscle associated with lung cancer cachexia.
van de Worp WRPH; Schols AMWJ; Dingemans AC; Op den Kamp CMH; Degens JHRJ; Kelders MCJM; Coort S; Woodruff HC; Kratassiouk G; Harel-Bellan A; Theys J; van Helvoort A; Langen RCJ
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):452-463. PubMed ID: 31828982
[TBL] [Abstract][Full Text] [Related]
2. Specific miRNAs are associated with human cancer cachexia in an organ-specific manner.
Krauss T; Heisz S; Honecker J; Prokopchuk O; Martignoni M; Janssen KP; Claussnitzer M; Hauner H; Seeliger C
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1381-1394. PubMed ID: 37021483
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
4. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
[TBL] [Abstract][Full Text] [Related]
5. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
6. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
7. Regulation of muscle atrophy by microRNAs: 'AtromiRs' as potential target in cachexia.
van de Worp WRPH; Theys J; van Helvoort A; Langen RCJ
Curr Opin Clin Nutr Metab Care; 2018 Nov; 21(6):423-429. PubMed ID: 30198917
[TBL] [Abstract][Full Text] [Related]
8. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
[TBL] [Abstract][Full Text] [Related]
9. Small RNAome profiling from human skeletal muscle: novel miRNAs and their targets associated with cancer cachexia.
Narasimhan A; Ghosh S; Stretch C; Greiner R; Bathe OF; Baracos V; Damaraju S
J Cachexia Sarcopenia Muscle; 2017 Jun; 8(3):405-416. PubMed ID: 28058815
[TBL] [Abstract][Full Text] [Related]
10. [TCM Combined Western Medicine Treatment of Advanced NSCLC: a Preliminary Study of mIRNA Expression Profiles].
Li YB; Lin LZ; Guan JS; Chen CM; Zuo Q; Lin BQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep; 36(9):1076-1081. PubMed ID: 30645846
[TBL] [Abstract][Full Text] [Related]
11. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y
Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945
[TBL] [Abstract][Full Text] [Related]
12. Decreased miR-497-5p Suppresses IL-6 Induced Atrophy in Muscle Cells.
Freire PP; Cury SS; Lopes LO; Fernandez GJ; Liu J; de Moraes LN; de Oliveira G; Oliveira JS; de Moraes D; Cabral-Marques O; Dal-Pai-Silva M; Hu X; Wang DZ; Carvalho RF
Cells; 2021 Dec; 10(12):. PubMed ID: 34944037
[TBL] [Abstract][Full Text] [Related]
13. Decoding the role of inflammation-related microRNAs in cancer cachexia: a study using HPV16-transgenic mice and in silico approaches.
Santos JMO; Peixoto da Silva S; Bastos MMSM; Oliveira PA; Gil da Costa RM; Medeiros R
J Physiol Biochem; 2022 May; 78(2):439-455. PubMed ID: 35298788
[TBL] [Abstract][Full Text] [Related]
14. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
15. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
[TBL] [Abstract][Full Text] [Related]
16. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
[TBL] [Abstract][Full Text] [Related]
17. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
Jin X; Guan Y; Zhang Z; Wang H
BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
[TBL] [Abstract][Full Text] [Related]
18. Cancer cachexia-induced muscle atrophy: evidence for alterations in microRNAs important for muscle size.
Lee DE; Brown JL; Rosa-Caldwell ME; Blackwell TA; Perry RA; Brown LA; Khatri B; Seo D; Bottje WG; Washington TA; Wiggs MP; Kong BW; Greene NP
Physiol Genomics; 2017 May; 49(5):253-260. PubMed ID: 28341621
[TBL] [Abstract][Full Text] [Related]
19. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
20. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y
Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
